CME Group Inc (NASDAQ:CME) CFO Sells $544,050.00 in Stock

CME Group Inc (NASDAQ:CME) CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $217.62, for a total value of $544,050.00. Following the sale, the chief financial officer now directly owns 30,354 shares in the company, valued at $6,605,637.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

CME Group stock opened at $202.94 on Friday. The business has a fifty day moving average of $211.18 and a two-hundred day moving average of $191.03. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The firm has a market cap of $73.56 billion, a P/E ratio of 29.76, a P/E/G ratio of 4.57 and a beta of 0.19. CME Group Inc has a twelve month low of $161.05 and a twelve month high of $224.91.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.01. The company had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. CME Group had a return on equity of 9.14% and a net margin of 39.36%. CME Group’s revenue was up 20.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.74 earnings per share. Equities analysts expect that CME Group Inc will post 6.69 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. The ex-dividend date is Monday, September 9th. This represents a $3.00 annualized dividend and a dividend yield of 1.48%. CME Group’s dividend payout ratio is presently 43.99%.

Several institutional investors and hedge funds have recently modified their holdings of CME. Dimensional Fund Advisors LP lifted its holdings in shares of CME Group by 2.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 906,174 shares of the financial services provider’s stock valued at $170,463,000 after purchasing an additional 24,717 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of CME Group by 12.9% during the 4th quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock valued at $885,776,000 after purchasing an additional 537,917 shares during the last quarter. Mercer Global Advisors Inc. ADV purchased a new stake in shares of CME Group during the 1st quarter valued at $304,000. Quantamental Technologies LLC purchased a new stake in shares of CME Group during the 1st quarter valued at $81,000. Finally, Moors & Cabot Inc. purchased a new stake in shares of CME Group during the 1st quarter valued at $204,000. Hedge funds and other institutional investors own 84.99% of the company’s stock.

A number of research analysts have recently commented on the company. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a research note on Thursday. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target for the company. in a report on Monday, May 27th. Barclays boosted their price target on CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a report on Thursday, May 23rd. Wells Fargo & Co boosted their price target on CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a report on Wednesday, July 3rd. Finally, UBS Group boosted their price target on CME Group from $191.00 to $214.00 and gave the company a “neutral” rating in a report on Thursday, September 5th. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $196.85.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: What is the Dividend Aristocrat Index?

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.